Cargando…
Long‐Term Results of Cultured Limbal Stem Cell Versus Limbal Tissue Transplantation in Stage III Limbal Deficiency
We aimed to evaluate efficiency and safety of transplantation of limbal stem cells (LSC) cultured on human amniotic membrane with no feeders and to compare cultured LSC with limbal tissue transplantation. Thirty eyes with stage III LSC deficiency were treated with autologous (autoLSC) or allogeneic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877763/ https://www.ncbi.nlm.nih.gov/pubmed/31486585 http://dx.doi.org/10.1002/sctm.19-0021 |
_version_ | 1783473402732871680 |
---|---|
author | Borderie, Vincent M. Ghoubay, Djida Georgeon, Cristina Borderie, Marie de Sousa, Céline Legendre, Anne Rouard, Hélène |
author_facet | Borderie, Vincent M. Ghoubay, Djida Georgeon, Cristina Borderie, Marie de Sousa, Céline Legendre, Anne Rouard, Hélène |
author_sort | Borderie, Vincent M. |
collection | PubMed |
description | We aimed to evaluate efficiency and safety of transplantation of limbal stem cells (LSC) cultured on human amniotic membrane with no feeders and to compare cultured LSC with limbal tissue transplantation. Thirty eyes with stage III LSC deficiency were treated with autologous (autoLSC) or allogeneic (alloLSC) cultured LSC transplantation (prospective phase II clinical trial; average follow‐up time, 72 months) or autologous (autoLT) or allogeneic (alloLT) limbal tissue transplantation (retrospective control group; average follow‐up time, 132 months) between 1993 and 2014. The 5‐year graft survival defined by absence of recurrence of the clinical signs of limbal deficiency was 71% for autoLSC, 0% for alloLSC, 75% for autoLT, and 33% for alloLT. Visual acuity improved by 9.2 lines for autoLSC and 3.3 lines for autoLT. It decreased by 0.7 lines for alloLSC and 1.9 lines for alloLT. Adverse events were recorded in 1/7 autoLSC, 7/7 alloLSC, 6/8 autoLT, and 8/8 alloLT patients. Corneal epithelial defect was the only adverse event recorded after autoLSC, whereas severe sight‐threatening adverse events were recorded in the remaining three groups. Compared with failed grafts, successful grafts featured greater decrease in fluorescein staining, greater superficial vascularization‐free corneal area, lower variability of the corneal epithelial thickness, and higher corneal epithelial basal cell density. Autologous cultured LSC transplantation was associated with high long‐term survival and dramatic improvement in vision and was very safe. Autologous limbal tissue transplantation resulted in similar efficiency but was less safe. Cadaver allogeneic grafts resulted in low long‐term success rate and high prevalence of serious adverse events. stem cells translational medicine 2019;8:1230&1241 |
format | Online Article Text |
id | pubmed-6877763 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68777632019-11-29 Long‐Term Results of Cultured Limbal Stem Cell Versus Limbal Tissue Transplantation in Stage III Limbal Deficiency Borderie, Vincent M. Ghoubay, Djida Georgeon, Cristina Borderie, Marie de Sousa, Céline Legendre, Anne Rouard, Hélène Stem Cells Transl Med Human Clinical Article We aimed to evaluate efficiency and safety of transplantation of limbal stem cells (LSC) cultured on human amniotic membrane with no feeders and to compare cultured LSC with limbal tissue transplantation. Thirty eyes with stage III LSC deficiency were treated with autologous (autoLSC) or allogeneic (alloLSC) cultured LSC transplantation (prospective phase II clinical trial; average follow‐up time, 72 months) or autologous (autoLT) or allogeneic (alloLT) limbal tissue transplantation (retrospective control group; average follow‐up time, 132 months) between 1993 and 2014. The 5‐year graft survival defined by absence of recurrence of the clinical signs of limbal deficiency was 71% for autoLSC, 0% for alloLSC, 75% for autoLT, and 33% for alloLT. Visual acuity improved by 9.2 lines for autoLSC and 3.3 lines for autoLT. It decreased by 0.7 lines for alloLSC and 1.9 lines for alloLT. Adverse events were recorded in 1/7 autoLSC, 7/7 alloLSC, 6/8 autoLT, and 8/8 alloLT patients. Corneal epithelial defect was the only adverse event recorded after autoLSC, whereas severe sight‐threatening adverse events were recorded in the remaining three groups. Compared with failed grafts, successful grafts featured greater decrease in fluorescein staining, greater superficial vascularization‐free corneal area, lower variability of the corneal epithelial thickness, and higher corneal epithelial basal cell density. Autologous cultured LSC transplantation was associated with high long‐term survival and dramatic improvement in vision and was very safe. Autologous limbal tissue transplantation resulted in similar efficiency but was less safe. Cadaver allogeneic grafts resulted in low long‐term success rate and high prevalence of serious adverse events. stem cells translational medicine 2019;8:1230&1241 John Wiley & Sons, Inc. 2019-09-05 /pmc/articles/PMC6877763/ /pubmed/31486585 http://dx.doi.org/10.1002/sctm.19-0021 Text en © 2019 The Authors. stem cells translational medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Human Clinical Article Borderie, Vincent M. Ghoubay, Djida Georgeon, Cristina Borderie, Marie de Sousa, Céline Legendre, Anne Rouard, Hélène Long‐Term Results of Cultured Limbal Stem Cell Versus Limbal Tissue Transplantation in Stage III Limbal Deficiency |
title | Long‐Term Results of Cultured Limbal Stem Cell Versus Limbal Tissue Transplantation in Stage III Limbal Deficiency |
title_full | Long‐Term Results of Cultured Limbal Stem Cell Versus Limbal Tissue Transplantation in Stage III Limbal Deficiency |
title_fullStr | Long‐Term Results of Cultured Limbal Stem Cell Versus Limbal Tissue Transplantation in Stage III Limbal Deficiency |
title_full_unstemmed | Long‐Term Results of Cultured Limbal Stem Cell Versus Limbal Tissue Transplantation in Stage III Limbal Deficiency |
title_short | Long‐Term Results of Cultured Limbal Stem Cell Versus Limbal Tissue Transplantation in Stage III Limbal Deficiency |
title_sort | long‐term results of cultured limbal stem cell versus limbal tissue transplantation in stage iii limbal deficiency |
topic | Human Clinical Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877763/ https://www.ncbi.nlm.nih.gov/pubmed/31486585 http://dx.doi.org/10.1002/sctm.19-0021 |
work_keys_str_mv | AT borderievincentm longtermresultsofculturedlimbalstemcellversuslimbaltissuetransplantationinstageiiilimbaldeficiency AT ghoubaydjida longtermresultsofculturedlimbalstemcellversuslimbaltissuetransplantationinstageiiilimbaldeficiency AT georgeoncristina longtermresultsofculturedlimbalstemcellversuslimbaltissuetransplantationinstageiiilimbaldeficiency AT borderiemarie longtermresultsofculturedlimbalstemcellversuslimbaltissuetransplantationinstageiiilimbaldeficiency AT desousaceline longtermresultsofculturedlimbalstemcellversuslimbaltissuetransplantationinstageiiilimbaldeficiency AT legendreanne longtermresultsofculturedlimbalstemcellversuslimbaltissuetransplantationinstageiiilimbaldeficiency AT rouardhelene longtermresultsofculturedlimbalstemcellversuslimbaltissuetransplantationinstageiiilimbaldeficiency |